TickerFactsScreenerDevelopers

GYRE THERAPEUTICS, INC. (GYRE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$24.27M2010: $138.30M2011: -$83.72M2012: -$64.24M2013: -$40.61M2017: -$19.94M2018: -$28.55M2019: -$43.61M2020: -$55.05M2021: -$83.75M2022: $10.68M2023: $25.89M2024: -$3.64M2025: $1.01M$1.01M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$1.01M+127.7%
2024-$3.64M-114.1%
2023$25.89M+142.5%
2022$10.68M+112.7%
2021-$83.75M-52.1%
2020-$55.05M-26.2%
2019-$43.61M-52.7%
2018-$28.55M-43.2%
2017-$19.94M—
2013-$40.61M+36.8%
2012-$64.24M+23.3%
2011-$83.72M-160.5%
2010$138.30M+669.8%
2009-$24.27M—